Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 20826697)

1.

The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization.

Bönsch C, Zuercher C, Lieby P, Kempf C, Ros C.

J Virol. 2010 Nov;84(22):11737-46. doi: 10.1128/JVI.01143-10. Epub 2010 Sep 8.

2.

Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.

Schmidt-Lucke C, Zobel T, Schrepfer S, Kuhl U, Wang D, Klingel K, Becher PM, Fechner H, Pozzuto T, Van Linthout S, Lassner D, Spillmann F, Escher F, Holinski S, Volk HD, Schultheiss HP, Tschope C.

J Infect Dis. 2015 Mar 24. pii: jiv178. [Epub ahead of print]

PMID:
25805750
3.

Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry.

Strauss M, Filman DJ, Belnap DM, Cheng N, Noel RT, Hogle JM.

J Virol. 2015 Apr;89(8):4143-57. doi: 10.1128/JVI.03101-14. Epub 2015 Jan 28.

PMID:
25631086
4.

Antiviral effect of cidofovir on parvovirus B19 replication.

Bonvicini F, Bua G, Manaresi E, Gallinella G.

Antiviral Res. 2015 Jan;113:11-8. doi: 10.1016/j.antiviral.2014.11.004. Epub 2014 Nov 13.

PMID:
25446336
5.

Human parvovirus B19: a review.

Rogo LD, Mokhtari-Azad T, Kabir MH, Rezaei F.

Acta Virol. 2014;58(3):199-213. Review.

PMID:
25283854
6.

Phosphatidylserine receptors: enhancers of enveloped virus entry and infection.

Moller-Tank S, Maury W.

Virology. 2014 Nov;468-470:565-80. doi: 10.1016/j.virol.2014.09.009. Epub 2014 Sep 29. Review.

PMID:
25277499
7.

Effects of human Parvovirus B19 and Bocavirus VP1 unique region on tight junction of human airway epithelial A549 cells.

Chiu CC, Shi YF, Yang JJ, Hsiao YC, Tzang BS, Hsu TC.

PLoS One. 2014 Sep 30;9(9):e107970. doi: 10.1371/journal.pone.0107970. eCollection 2014.

8.

Coat as a dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking.

Bilkova E, Forstova J, Abrahamyan L.

Viruses. 2014 Jul 23;6(7):2899-937. doi: 10.3390/v6072899. Review.

9.

Parvovirus glycan interactions.

Huang LY, Halder S, Agbandje-McKenna M.

Curr Opin Virol. 2014 Aug;7:108-18. doi: 10.1016/j.coviro.2014.05.007. Epub 2014 Jul 19. Review.

PMID:
25047752
10.

Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process.

Adamson-Small LA, Ignatovich IV, Laemmerhirt MG, Hobbs JA.

Virus Res. 2014 Sep 22;190:8-16. doi: 10.1016/j.virusres.2014.06.017. Epub 2014 Jul 3. Review.

PMID:
24998884
11.

Parvovirus B19 VLP recognizes globoside in supported lipid bilayers.

Nasir W, Nilsson J, Olofsson S, Bally M, Rydell GE.

Virology. 2014 May;456-457:364-9. doi: 10.1016/j.virol.2014.04.004. Epub 2014 Apr 28.

12.

Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.

von Kietzell K, Pozzuto T, Heilbronn R, Grössl T, Fechner H, Weger S.

J Virol. 2014 Jul;88(14):8102-15. doi: 10.1128/JVI.00649-14. Epub 2014 May 7.

13.

Lysine addressability and mammalian cell interactions of bacteriophage λ procapsids.

Koudelka KJ, Ippoliti S, Medina E, Shriver LP, Trauger SA, Catalano CE, Manchester M.

Biomacromolecules. 2013 Dec 9;14(12):4169-76. doi: 10.1021/bm401577f. Epub 2013 Nov 26.

PMID:
24251756
14.

Single-cell chemiluminescence imaging of parvovirus B19 life cycle.

Bonvicini F, Mirasoli M, Manaresi E, Bua G, Calabria D, Roda A, Gallinella G.

Virus Res. 2013 Dec 26;178(2):517-21. doi: 10.1016/j.virusres.2013.09.037. Epub 2013 Oct 4.

PMID:
24100233
15.

Human parvovirus B19 infection leads to downregulation of thyroid, estrogen, and retinoid hormone receptor expression.

Ignatovich IV, Hobbs JA.

Virology. 2013 Nov;446(1-2):173-9. doi: 10.1016/j.virol.2013.06.022. Epub 2013 Aug 28.

16.

Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.

Leisi R, Ruprecht N, Kempf C, Ros C.

J Virol. 2013 Dec;87(24):13161-7. doi: 10.1128/JVI.02548-13. Epub 2013 Sep 25.

17.

The structure and host entry of an invertebrate parvovirus.

Meng G, Zhang X, Plevka P, Yu Q, Tijssen P, Rossmann MG.

J Virol. 2013 Dec;87(23):12523-30. doi: 10.1128/JVI.01822-13. Epub 2013 Sep 11.

18.

Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication.

Brandt MR, Kirste AG, Pozzuto T, Schubert S, Kandolf R, Fechner H, Bock CT, Kurreck J.

Virus Res. 2013 Sep;176(1-2):155-60. doi: 10.1016/j.virusres.2013.05.020. Epub 2013 Jun 13.

PMID:
23770153
19.

Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.

Wolfisberg R, Ruprecht N, Kempf C, Ros C.

J Virol Methods. 2013 Oct;193(1):215-25. doi: 10.1016/j.jviromet.2013.06.003. Epub 2013 Jun 10.

PMID:
23764418
20.

The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.

Deng X, Dong Y, Yi Q, Huang Y, Zhao D, Yang Y, Tijssen P, Qiu J, Liu K, Li Y.

PLoS One. 2013 Apr 15;8(4):e61440. doi: 10.1371/journal.pone.0061440. Print 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk